Stock Fundamentals

SLN.US Logo

SLN.US - Current Price

$6.31

Company Information

Company Name
Silence Therapeutics PLC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US82686Q1013
CIK: 0001479615
CUSIP: 82686Q101
Currency: USD
Full Time Employees: 116
Phone: 44 20 3457 6900
Fiscal Year End: December
IPO Date: Sep 08, 2020
Description:

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Zerlasiran (SLN360), which is in Phase II clinical trial for cardiovascular disease associated with elevated lipoprotein(a); Divesiran (SLN124), an siRNA molecule that is in Phase I clinical trial for the treatment of genetic hematological conditions, including polycythemia vera; and SLN548 for complement-mediated disease. Silence Therapeutics plc has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize siRNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and Hansoh Pharmaceutical Group Company Limited to develop siRNAs. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, the United Kingdom.

Address:

72 Hammersmith Road, London, United Kingdom, W14 8TH

Directors & Officers

Name Title Year Born
Mr. Craig A. Tooman M.B.A. President, CEO & Executive Director 1965
Ms. Rhonda L. Hellums Executive VP, CFO & Secretary 1972
Dr. Steven J. Romano M.D. Executive VP and Chief Research & Development Officer 1959
Dr. Marie Wikstrom Lindholm Ph.D. Chief Scientific Officer NA
Ms. Gem Gokmen Hopkins Head of IR & Corporate Communications NA
Mr. Jaimin B. Shah SVP & General Counsel NA
Ms. Gianine Esposito Chief Human Resources Officer NA
Mr. J.P. Gabriel Chief Technical Operations Officer NA
Mr. Curtis Rambaran M.D. Chief Medical Officer NA

Shares Statistics

Shares Outstanding: 47.23M
Shares Float: 74.75M
% Insiders: 2,437.70%
% Institutions: 4,199.60%
Short % Float: 1.49%

Valuation Metrics

Enterprise Value: $124.71M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $326.86M
EBITDA: $-69.41M
Book Value: $1.57
Earnings/Share: $-1.35
Profit Margin: -249.86%
Operating Margin: -14,881.13%
ROA (TTM): -23.40%
ROE (TTM): -64.30%
Revenue (TTM): $25.83M
Revenue/Share (TTM): $0.54
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -89.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.20 N/A 10,000.00%
Sep 30, 2025 -0.15 -0.21 N/A 2,857.14%
Jun 30, 2025 -0.55 -0.21 N/A -16,190.48%
Mar 31, 2025 -0.60 -0.41 N/A -4,634.15%
Dec 31, 2024 0.17 -0.25 N/A 16,933.12%
Sep 30, 2024 -0.73 -0.14 N/A -42,142.86%
Jun 30, 2024 -0.43 -0.11 N/A -27,353.71%
Mar 31, 2024 -0.05 -0.11 N/A 5,270.98%
Dec 31, 2023 -0.45 -0.08 N/A -48,007.71%
Sep 30, 2023 -0.07 -0.17 N/A 5,882.35%
Jun 30, 2023 -0.12 -0.17 N/A 2,920.76%
Mar 31, 2023 -0.12 -0.15 N/A 2,127.66%
Dec 31, 2022 0.45 -0.01 N/A 374,838.71%
Sep 30, 2022 -0.08 -0.20 N/A 5,818.00%
Jun 30, 2022 -0.15 -0.20 N/A 2,259.05%
Mar 31, 2022 -0.11 -0.19 N/A 4,475.89%
Dec 31, 2021 -0.14 -0.14 N/A -42.34%
Sep 30, 2021 -0.15 -0.15 N/A 197.37%
Jun 30, 2021 -0.31 0.85 N/A -13,691.06%
Mar 31, 2021 -0.55 -0.55 N/A 0.00%
Dec 31, 2020 -0.16 0.00 N/A N/A
Sep 30, 2020 -0.18 0.00 N/A N/A
Jun 30, 2020 -0.14 0.00 N/A N/A
Mar 31, 2020 -0.08 0.00 N/A N/A
Dec 31, 2019 -0.09 0.00 N/A N/A
Sep 30, 2019 -0.10 0.00 N/A N/A
Jun 30, 2019 -0.09 0.00 N/A N/A
Mar 31, 2019 -0.07 0.00 N/A N/A
Dec 31, 2018 -0.08 0.00 N/A N/A
Sep 30, 2018 -0.09 0.00 N/A N/A
Jun 30, 2018 -0.09 0.00 N/A N/A
Mar 31, 2018 -0.08 0.00 N/A N/A
Dec 31, 2017 -0.09 0.00 N/A N/A
Sep 30, 2017 0.04 0.00 N/A N/A
Jun 30, 2017 0.04 0.00 N/A N/A
Mar 31, 2017 -0.05 0.00 N/A N/A
Dec 31, 2016 -0.05 0.00 N/A N/A
Sep 30, 2016 -0.03 0.00 N/A N/A
Jun 30, 2016 -0.03 0.00 N/A N/A
Mar 31, 2016 -0.05 0.00 N/A N/A
Dec 31, 2015 -0.05 0.00 N/A N/A
Sep 30, 2015 -0.03 0.00 N/A N/A
Jun 30, 2015 -0.03 0.00 N/A N/A
Mar 31, 2015 -0.06 0.00 N/A N/A
Dec 31, 2014 -0.05 0.00 N/A N/A
Sep 30, 2014 -0.08 0.00 N/A N/A
Jun 30, 2014 -0.09 0.00 N/A N/A
Mar 31, 2014 -0.10 0.00 N/A N/A
Dec 31, 2013 -0.10 0.00 N/A N/A
Sep 30, 2013 -0.10 0.00 N/A N/A
Jun 30, 2013 -0.10 0.00 N/A N/A
Mar 31, 2013 -0.06 0.00 N/A N/A
Dec 31, 2012 -0.06 0.00 N/A N/A
Sep 30, 2012 -0.08 0.00 N/A N/A
Jun 30, 2012 -0.08 0.00 N/A N/A
Mar 31, 2012 -1.60 0.00 N/A N/A
Dec 31, 2011 -1.63 0.00 N/A N/A
Sep 30, 2011 -0.15 0.00 N/A N/A
Jun 30, 2011 -0.16 0.00 N/A N/A
Mar 31, 2011 -0.39 0.00 N/A N/A
Dec 31, 2010 -0.39 0.00 N/A N/A
Sep 30, 2010 -0.24 0.00 N/A N/A

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $121.33M $N/A $202.64M $68.61M $134.02M
2023-12-31 $68.79M $N/A $119.45M $97.46M $21.99M
2022-12-31 $54.82M $N/A $107.50M $85.43M $22.07M
2021-12-31 $73.54M $N/A $96.19M $87.67M $8.53M
2020-12-31 $27.45M $N/A $85.97M $76.91M $9.06M
2019-12-31 $13.52M $N/A $46.08M $25.17M $20.91M
2018-12-31 $21.49M $N/A $38.89M $3.83M $35.06M
2017-12-31 $42.75M $N/A $55.01M $2.66M $52.35M
2016-12-31 $39.01M $N/A $55.79M $1.61M $54.18M
2015-12-31 $51.91M $N/A $61.55M $1.12M $60.43M
2014-12-31 $16.86M $N/A $29.77M $2.01M $27.76M
2013-12-31 $15.89M $N/A $29.30M $1.72M $27.58M
2012-12-31 $8.91M $N/A $17.08M $959.00K $16.12M
2011-12-31 $3.69M $N/A $33.44M $1.26M $32.18M
2010-12-31 $3.57M $N/A $33.96M $1.69M $32.27M
2009-12-31 $1.13M $N/A $10.99M $2.10M $8.89M
2008-12-31 $3.35M $N/A $14.38M $935.00K $13.44M
2007-12-31 $10.17M $N/A $19.48M $1.80M $17.68M
2006-12-31 $8.82M $N/A $16.75M $1.04M $15.71M
2005-12-31 $9.09M $N/A $17.17M $1.49M $15.69M
2004-12-31 $2.63M $N/A $3.19M $846.00K $2.34M
2003-12-31 $5.09M $N/A $6.49M $1.31M $5.18M
2002-12-31 $7.16M $N/A $8.49M $1.03M $7.46M
2001-12-31 $9.08M $N/A $9.67M $725.00K $8.95M
2000-12-31 $11.43M $N/A $12.10M $964.00K $11.14M
1999-12-31 $10.53M $N/A $10.81M $1.60M $9.21M
1998-12-31 $3.66M $N/A $3.95M $603.00K $3.34M
1997-12-31 $5.18M $N/A $5.27M $640.00K $4.63M
1996-12-31 $6.70M $N/A $6.81M $417.00K $6.39M
1995-12-31 $1.25M $N/A $3.06M $301.00K $2.76M

Watchlist

0

No stocks in watchlist